Cancer researchers are beginning to ask why Roche 's very expensive and very lucrative drug Avastin is not providing bigger survival gains for cancer patients. Avastin aims to starve tumors by cutting ...

(CBS/AP) The cancer drug Avastin has come under fire in recent years as studies have showed it doesn't prolong life for patients with breast cancer and may cause nasty side effects. The controversy ...

Intensifying the chemotherapy component of a standard regimen containing Avastin reduced the risk of death and increased five-year overall survival in newly diagnosed metastatic colorectal cancer.

In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin ...

Women with advanced breast cancer who were treated with Roche's Avastin were more likely to develop heart failure than other women, according to an analysis released on Tuesday that raised more ...

Medicare to continue to cover Avastin for breast cancer treatment, despite FDA. June 30, 2011 — -- Medicare will continue to cover Avastin for breast cancer treatment even if U.S. Food and Drug ...

First, some background. In 2004, the FDA approved Avastin for first-line treatment of patients with metastatic, or malignant, colorectal cancer. The tremendous success of Avastin turned Genentech from ...

For women with advanced cases of ovarian cancer, the drug Avastin adds about four months to the time it takes for the cancer to worsen, according to a new report. Patients treated with Avastin in ...

Fake version does not contain the cancer-fighting ingredient, FDA warns. Feb. 15, 2012— -- Cancer patients are furious that a counterfeit version of the drug Avastin has landed in U.S. clinics.

Update 4:06 p.m.: A panel advising the Food and Drug Administration voted against an appeal by Genentech to preserve the approval of Avastin as a treatment for advanced breast cancer. In unanimous ...

Federal health authorities recommended Thursday that the blockbuster drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug's original promise to help ...